Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference89 articles.
1. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A Review. JAMA.
2. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell.
3. Sodhi CP, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton WB, Wang S et al (2018) Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am J Phys Lung Cell Mol Phys 314(1):L17–L31
4. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD et al (2007) The emerging role of ACE2 in physiology and disease. J Pathol 212(1):1–11
5. Burrell LM, Harrap SB, Velkoska E, Patel SK (2013) The ACE2 gene: its potential as a functional candidate for cardiovascular disease. Clin Sci 124(2):65–76
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献